Polaris Market Research has published its latest research report titled Gene Therapy Market Size, Share, Trends, Industry Analysis Report: By Therapeutic Area, Vector Type (Viral, Non-Viral), Approach, Route of Administration, and Region – Market Forecast 2026–2034. The report examines the global Gene Therapy Market , covering its current size, market share, growth prospects, and industry developments. It discusses the factors influencing demand and provides an overview of the changes taking place across the industry.

The study covers the market at global and regional levels. It considers developments in the industry, changing customer requirements, and factors affecting business activity. The research also looks at the challenges faced by market participants and areas where new business opportunities may emerge.

The report draws on primary and secondary research to assess the market. It considers economic conditions, technological developments, regulatory requirements, and other factors relevant to the industry. The findings offer useful information to businesses, investors, and other stakeholders assessing the market.

Market Size and Forecast

The gene therapy market was valued at USD 2.66 billion in 2025 and is expected to increase from USD 3.29 billion in 2026 to USD 29.01 billion by 2034, registering a CAGR of 27.1% during the forecast period from 2026 to 2034. Market growth is driven by advancements in genetic engineering, increasing research and development activities, and rising demand for innovative treatments for genetic and rare diseases.

The report includes historical data and future estimates to show how the market is expected to develop during the forecast period.

Market Dynamics

Several factors influence the direction of the Gene Therapy market. The report considers the following areas to understand their effect on market activity:

Supply and Demand: The report looks at product or service availability and the level of demand in the market. It also considers changes in purchasing requirements and consumption patterns within the sector.

Technological Advancements: The study covers the introduction of new technologies and their effect on existing products, services, and industry practices. It also looks at how technological changes influence product development and market applications.

Regulatory and Legal Environment: The report considers the laws, government policies, and industry standards applicable to the Gene Therapy market. It also looks at how regulatory changes affect companies and their operations.

Economic Factors: The study takes into account economic conditions such as inflation, interest rates, income levels, and economic growth. These factors are considered in relation to their influence on demand and investment in the market.

Browse Full Insights:

https://www.polarismarketresearch.com/industry-analysis/gene-therapy-market

Key Market Trends

The report highlights important developments in the Gene Therapy market. It looks at changes in customer preferences, product offerings, industry practices, and the adoption of new technologies. The discussion also covers recent developments that may influence market demand and business decisions.

The study considers how these changes are affecting market participants and their approach to product development, business expansion, and customer requirements.

Competitive Landscape

The report identifies the major companies operating in the Gene Therapy market. It provides an overview of their business operations, product or service offerings, and market presence. The study also covers recent company developments and strategies used to strengthen their positions.

These strategies may include product launches, partnerships, mergers and acquisitions, research and development, and geographical expansion. A SWOT analysis of major market participants is also included. The report discusses potential entry barriers and other challenges that may affect competition.

Some of the key market players include:

• Sangamo Biosciences
• Voyager Therapeutics
• Ultragenyx
• GlaxoSmithKline
• Gilead Sciences Inc
• Bristol Myers Squibb
• Novartis AG
• Spark Therapeutics LLC
• Bluebird Bio

Market Segmentation

By Type Therapeutic Area Outlook (Revenue, USD Billion, 2021–2034)

• Autoimmune Disorders
• Cardiovascular Diseases
• Dermatological Disorders
• Hematological Disorders
• Metabolic Disorders
• Muscle-related Diseases
• Oncological Disorders
• Others

By Vector Type Outlook (Revenue, USD Billion, 2021–2034)

• Viral
• Non-Viral

By Approach Outlook (Revenue, USD Billion, 2021–2034)

• Gene Augmentation
• Oncolytic Viral Therapy
• Immunotherapy
• Other Approaches

By Route of Administration Outlook (Revenue, USD Billion, 2021–2034)

• Intraarticular
• Intracerebellar
• Intradermal
• Intramuscular
• Intratumoral
• Intravenous
• Intravesical
• Intravitreal
• Subretinal
• Others

The Report Answers Questions Such As

• What is the current size of the global Gene Therapy market?
• What is the projected market size by the end of the forecast period?
• What CAGR is expected during the forecast period?
• What factors are influencing market growth?
• What are the major trends shaping the industry?
• Which segment accounts for the largest market share?
• Which segment is expected to grow at the fastest rate?
• Which region holds the largest market share?
• Who are the leading companies operating in the market?
• What opportunities are available to existing and new market participants?

More Trending Latest Reports By Polaris Market Research:

Organ-on-Chip Market Analysis

Industrial Gases Market Opportunities

Cloud Migration Services Market Trends

AI Toolkit Market Size

Aircraft Hydraulic Systems Market Share

Urban Air Mobility Market Growth

Spine Biologics Market Forecast

Next-generation Firewall Market Analysis

AI Code Tools Market Opportunities

Radiation Hardened Electronics Market Trends